Recent therapeutic advances in chronic lymphocytic leukemia

por Bose, Prithviraj, Gandhi, Varsha
Publicado 2017

Managing chronic lymphocytic leukemia in 2020: an update on recent clinical advances with a focus on BTK and BCL-2 inhibitors

por Bose, Prithviraj, Gandhi, Varsha
Publicado 2021

Ibrutinib combinations in CLL therapy: scientific rationale and clinical results

por Timofeeva, Natalia, Gandhi, Varsha
Publicado 2021

Recruitment challenges in physiotherapy trials

por Gandhi, Varsha, Cooper, Cushla, Barker, Karen
Publicado 2015

Curing CLL: one clone at a time

por Aslan, Burcu, Tantawy, Shady I., Gandhi, Varsha
Publicado 2022

Targeting MCL-1 protein to treat cancer: opportunities and challenges

por Tantawy, Shady I., Timofeeva, Natalia, Sarkar, Aloke, Gandhi, Varsha
Publicado 2023

Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug

por WANG, JIN, YIN, HAILIN, PANANDIKAR, ASHWINI, GANDHI, VARSHA, SEN, SUBRATA
Publicado 2015

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

por Tantawy, Shady I., Timofeeva, Natalia, Hernandez, Ana, Sarkar, Aloke, Gandhi, Varsha
Publicado 2023

What evidence is used to underpin the design of strength-based exercise interventions evaluated in randomised controlled trials for rheumatoid arthritis? A systematic review protoc...

por Boniface, Graham, Norris, Meriel, Williamson, Esther, Gandhi, Varsha, Kirtley, Shona, O’Connell, Neil
Publicado 2018

Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes

por Chen, Wenbing, Balakrishnan, Kumudha, Kuang, Yunyan, Han, Yanyan, Fu, Min, Gandhi, Varsha, Peng, Xiaohua
Publicado 2014

Regulation of Mcl-1 Expression in Context to Bone Marrow Stromal Microenvironment in Chronic Lymphocytic Leukemia()

por Balakrishnan, Kumudha, Burger, Jan A., Fu, Min, Doifode, Tejaswini, Wierda, William G., Gandhi, Varsha
Publicado 2014

Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic

por Balakrishnan, Kumudha, Fu, Min, Onida, Francesco, Wierda, William G., Keating, Michael J., Gandhi, Varsha
Publicado 2016

Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells

por Modi, Prexy, Balakrishnan, Kumudha, Yang, Qingshan, Wierda, William G., Keating, Michael J., Gandhi, Varsha
Publicado 2017

A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis

por Boniface, Graham, Gandhi, Varsha, Norris, Meriel, Williamson, Esther, Kirtley, Shona, O’Connell, Neil E
Publicado 2020

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma

por Sarkar, Aloke, Balakrishnan, Kumudha, Chen, Jefferson, Patel, Viralkumar, Neelapu, Sattva S., McMurray, John S., Gandhi, Varsha
Publicado 2015

Targeting the Pro-Survival Protein MET with Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()

por Zaman, Shadia, Shentu, Shujun, Yang, Jing, He, Jin, Orlowski, Robert Z., Stellrecht, Christine M., Gandhi, Varsha
Publicado 2015

Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia

por Yi, Xue, Jain, Nitin, Iles, LaKesla R., Ayres, Mary L., Wierda, William G., Gandhi, Varsha
Publicado 2022

PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells

por Cervantes-Gomez, Fabiola, Stellrecht, Christine M., Ayres, Mary L., Keating, Michael J., Wierda, William G., Gandhi, Varsha
Publicado 2019

8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition

por Kearney, Alper Y., Fan, You-Hong, Giri, Uma, Saigal, Babita, Gandhi, Varsha, Heymach, John V., Zurita, Amado J.
Publicado 2015

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase

por Aslan, Burcu, Hubner, Stefan Edward, Fox, Judith A., Taverna, Pietro, Wierda, William G., Kornblau, Steven M., Gandhi, Varsha
Publicado 2021